Software - Application
Compare Stocks
5 / 10Stock Comparison
PEGA vs NICE vs CRM vs NOW vs ORCL
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Software - Application
Software - Application
Software - Infrastructure
PEGA vs NICE vs CRM vs NOW vs ORCL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Software - Application | Software - Application | Software - Application | Software - Infrastructure |
| Market Cap | $6.21B | $5.78B | $179.19B | $96.96B | $559.27B |
| Revenue (TTM) | $1.70B | $2.95B | $41.52B | $13.96B | $64.08B |
| Net Income (TTM) | $341M | $612M | $7.46B | $1.76B | $16.21B |
| Gross Margin | 75.0% | 66.4% | 77.7% | 76.6% | 66.4% |
| Operating Margin | 10.2% | 21.9% | 21.5% | 13.4% | 30.8% |
| Forward P/E | 13.5x | 8.7x | 15.8x | 22.5x | 26.0x |
| Total Debt | $76M | $164M | $6.74B | $3.20B | $104.10B |
| Cash & Equiv. | $212M | $379M | $7.33B | $3.73B | $10.79B |
PEGA vs NICE vs CRM vs NOW vs ORCL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Pegasystems Inc. (PEGA) | 100 | 77.2 | -22.8% |
| NICE Ltd. (NICE) | 100 | 51.4 | -48.6% |
| Salesforce, Inc. (CRM) | 100 | 106.6 | +6.6% |
| ServiceNow, Inc. (NOW) | 100 | 24.1 | -75.9% |
| Oracle Corporation (ORCL) | 100 | 361.8 | +261.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PEGA vs NICE vs CRM vs NOW vs ORCL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PEGA ranks third and is worth considering specifically for efficiency.
- 23.5% ROA vs CRM's 6.6%, ROIC 27.2% vs 10.9%
NICE has the current edge in this matchup, primarily because of its strength in sleep-well-at-night.
- Lower volatility, beta 0.72, Low D/E 4.2%, current ratio 1.55x
- Lower P/E (8.7x vs 26.0x), PEG 0.33 vs 3.66
- Beta 0.72 vs ORCL's 1.59, lower leverage
CRM is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 2 yrs, beta 0.82, yield 0.9%
- Beta 0.82, yield 0.9%, current ratio 0.76x
- 0.9% yield, 2-year raise streak, vs ORCL's 0.9%, (2 stocks pay no dividend)
NOW is the clearest fit if your priority is growth exposure and valuation efficiency.
- Rev growth 20.9%, EPS growth 21.9%, 3Y rev CAGR 22.4%
- PEG 0.32 vs ORCL's 3.66
- 20.9% revenue growth vs NICE's 7.7%
ORCL is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 425.1% 10Y total return vs PEGA's 188.8%
- 25.3% margin vs NOW's 12.6%
- +31.6% vs NOW's -90.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.9% revenue growth vs NICE's 7.7% | |
| Value | Lower P/E (8.7x vs 26.0x), PEG 0.33 vs 3.66 | |
| Quality / Margins | 25.3% margin vs NOW's 12.6% | |
| Stability / Safety | Beta 0.72 vs ORCL's 1.59, lower leverage | |
| Dividends | 0.9% yield, 2-year raise streak, vs ORCL's 0.9%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +31.6% vs NOW's -90.5% | |
| Efficiency (ROA) | 23.5% ROA vs CRM's 6.6%, ROIC 27.2% vs 10.9% |
PEGA vs NICE vs CRM vs NOW vs ORCL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PEGA vs NICE vs CRM vs NOW vs ORCL — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NICE leads in 1 of 6 categories
PEGA leads 1 • ORCL leads 1 • CRM leads 0 • NOW leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — CRM and ORCL each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ORCL is the larger business by revenue, generating $64.1B annually — 37.7x PEGA's $1.7B. ORCL is the more profitable business, keeping 25.3% of every revenue dollar as net income compared to NOW's 12.6%. On growth, NOW holds the edge at +22.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.7B | $2.9B | $41.5B | $14.0B | $64.1B |
| EBITDAEarnings before interest/tax | $193M | $845M | $11.4B | $2.7B | $26.5B |
| Net IncomeAfter-tax profit | $341M | $612M | $7.5B | $1.8B | $16.2B |
| Free Cash FlowCash after capex | $495M | $665M | $14.4B | $4.6B | -$24.7B |
| Gross MarginGross profit ÷ Revenue | +75.0% | +66.4% | +77.7% | +76.6% | +66.4% |
| Operating MarginEBIT ÷ Revenue | +10.2% | +21.9% | +21.5% | +13.4% | +30.8% |
| Net MarginNet income ÷ Revenue | +20.0% | +20.8% | +18.0% | +12.6% | +25.3% |
| FCF MarginFCF ÷ Revenue | +29.1% | +22.6% | +34.7% | +33.2% | -38.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -9.6% | +9.0% | +12.1% | +22.1% | +21.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -60.0% | +56.5% | +18.3% | +2.3% | +24.5% |
Valuation Metrics
NICE leads this category, winning 7 of 7 comparable metrics.
Valuation Metrics
At 9.9x trailing earnings, NICE trades at a 82% valuation discount to NOW's 56.0x P/E. Adjusting for growth (PEG ratio), NICE offers better value at 0.37x vs ORCL's 6.31x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $6.2B | $5.8B | $179.2B | $97.0B | $559.3B |
| Enterprise ValueMkt cap + debt − cash | $6.1B | $5.6B | $178.6B | $96.4B | $652.6B |
| Trailing P/EPrice ÷ TTM EPS | 17.24x | 9.89x | 23.88x | 56.04x | 44.82x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.52x | 8.74x | 15.82x | 22.51x | 25.99x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.37x | 1.95x | 0.81x | 6.31x |
| EV / EBITDAEnterprise value multiple | 21.01x | 6.59x | 20.03x | 37.64x | 27.36x |
| Price / SalesMarket cap ÷ Revenue | 3.56x | 1.96x | 4.32x | 7.30x | 9.74x |
| Price / BookPrice ÷ Book value/share | 8.62x | 1.56x | 3.01x | 7.56x | 26.59x |
| Price / FCFMarket cap ÷ FCF | 12.65x | 8.22x | 12.44x | 21.19x | — |
Profitability & Efficiency
PEGA leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ORCL delivers a 56.3% return on equity — every $100 of shareholder capital generates $56 in annual profit, vs $13 for CRM. NICE carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to ORCL's 4.96x. On the Piotroski fundamental quality scale (0–9), PEGA scores 8/9 vs NOW's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +50.2% | +16.4% | +12.6% | +15.0% | +56.3% |
| ROA (TTM)Return on assets | +23.5% | +11.8% | +6.6% | +7.5% | +8.1% |
| ROICReturn on invested capital | +27.2% | +13.2% | +10.9% | +12.4% | +12.8% |
| ROCEReturn on capital employed | +33.4% | +16.1% | +11.9% | +13.2% | +14.4% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 | 8 | 3 | 6 |
| Debt / EquityFinancial leverage | 0.10x | 0.04x | 0.11x | 0.25x | 4.96x |
| Net DebtTotal debt minus cash | -$136M | -$216M | -$590M | -$523M | $93.3B |
| Cash & Equiv.Liquid assets | $212M | $379M | $7.3B | $3.7B | $10.8B |
| Total DebtShort + long-term debt | $76M | $164M | $6.7B | $3.2B | $104.1B |
| Interest CoverageEBIT ÷ Interest expense | 643.17x | — | 44.14x | 185.08x | 5.44x |
Total Returns (Dividends Reinvested)
ORCL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ORCL five years ago would be worth $25,183 today (with dividends reinvested), compared to $1,935 for NOW. Over the past 12 months, ORCL leads with a +31.6% total return vs NOW's -90.5%. The 3-year compound annual growth rate (CAGR) favors ORCL at 27.3% vs NOW's -40.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -34.4% | -14.6% | -26.4% | -36.5% | -0.1% |
| 1-Year ReturnPast 12 months | -20.8% | -40.4% | -32.4% | -90.5% | +31.6% |
| 3-Year ReturnCumulative with dividends | +68.5% | -49.3% | -4.0% | -78.7% | +106.5% |
| 5-Year ReturnCumulative with dividends | -38.3% | -59.1% | -12.3% | -80.6% | +151.8% |
| 10-Year ReturnCumulative with dividends | +188.8% | +50.7% | +154.6% | +38.8% | +425.1% |
| CAGR (3Y)Annualised 3-year return | +19.0% | -20.2% | -1.4% | -40.3% | +27.3% |
Risk & Volatility
Evenly matched — NICE and CRM each lead in 1 of 2 comparable metrics.
Risk & Volatility
NICE is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than ORCL's 1.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CRM currently trades 62.9% from its 52-week high vs NOW's 8.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.16x | 0.72x | 0.82x | 1.46x | 1.59x |
| 52-Week HighHighest price in past year | $68.10 | $180.61 | $296.05 | $1057.39 | $345.72 |
| 52-Week LowLowest price in past year | $34.34 | $94.89 | $163.52 | $81.24 | $134.57 |
| % of 52W HighCurrent price vs 52-week peak | +53.9% | +53.0% | +62.9% | +8.9% | +56.3% |
| RSI (14)Momentum oscillator 0–100 | 38.8 | 40.9 | 48.3 | 41.5 | 68.5 |
| Avg Volume (50D)Average daily shares traded | 2.2M | 631K | 12.4M | 21.2M | 26.3M |
Analyst Outlook
Evenly matched — CRM and ORCL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PEGA as "Buy", NICE as "Buy", CRM as "Buy", NOW as "Buy", ORCL as "Buy". Consensus price targets imply 61.9% upside for NOW (target: $152) vs 32.2% for ORCL (target: $257). For income investors, CRM offers the higher dividend yield at 0.89% vs PEGA's 0.23%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $56.60 | $150.88 | $287.00 | $151.52 | $257.19 |
| # AnalystsCovering analysts | 23 | 23 | 97 | 68 | 86 |
| Dividend YieldAnnual dividend ÷ price | +0.2% | — | +0.9% | — | +0.9% |
| Dividend StreakConsecutive years of raises | 1 | 0 | 2 | — | 18 |
| Dividend / ShareAnnual DPS | $0.08 | — | $1.66 | — | $1.65 |
| Buyback YieldShare repurchases ÷ mkt cap | +8.3% | +8.5% | +7.0% | +1.9% | +0.3% |
NICE leads in 1 of 6 categories (Valuation Metrics). PEGA leads in 1 (Profitability & Efficiency). 3 tied.
PEGA vs NICE vs CRM vs NOW vs ORCL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PEGA or NICE or CRM or NOW or ORCL a better buy right now?
For growth investors, ServiceNow, Inc.
(NOW) is the stronger pick with 20. 9% revenue growth year-over-year, versus 7. 7% for NICE Ltd. (NICE). NICE Ltd. (NICE) offers the better valuation at 9. 9x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate Pegasystems Inc. (PEGA) a "Buy" — based on 23 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PEGA or NICE or CRM or NOW or ORCL?
On trailing P/E, NICE Ltd.
(NICE) is the cheapest at 9. 9x versus ServiceNow, Inc. at 56. 0x. On forward P/E, NICE Ltd. is actually cheaper at 8. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ServiceNow, Inc. wins at 0. 32x versus Oracle Corporation's 3. 66x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PEGA or NICE or CRM or NOW or ORCL?
Over the past 5 years, Oracle Corporation (ORCL) delivered a total return of +151.
8%, compared to -80. 6% for ServiceNow, Inc. (NOW). Over 10 years, the gap is even starker: ORCL returned +425. 1% versus NOW's +38. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PEGA or NICE or CRM or NOW or ORCL?
By beta (market sensitivity over 5 years), NICE Ltd.
(NICE) is the lower-risk stock at 0. 72β versus Oracle Corporation's 1. 59β — meaning ORCL is approximately 119% more volatile than NICE relative to the S&P 500. On balance sheet safety, NICE Ltd. (NICE) carries a lower debt/equity ratio of 4% versus 5% for Oracle Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — PEGA or NICE or CRM or NOW or ORCL?
By revenue growth (latest reported year), ServiceNow, Inc.
(NOW) is pulling ahead at 20. 9% versus 7. 7% for NICE Ltd. (NICE). On earnings-per-share growth, the picture is similar: Pegasystems Inc. grew EPS 287. 3% year-over-year, compared to 17. 0% for Oracle Corporation. Over a 3-year CAGR, NOW leads at 22. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PEGA or NICE or CRM or NOW or ORCL?
Pegasystems Inc.
(PEGA) is the more profitable company, earning 22. 5% net margin versus 13. 2% for ServiceNow, Inc. — meaning it keeps 22. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ORCL leads at 30. 8% versus 13. 7% for NOW. At the gross margin level — before operating expenses — CRM leads at 77. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PEGA or NICE or CRM or NOW or ORCL more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ServiceNow, Inc. (NOW) is the more undervalued stock at a PEG of 0. 32x versus Oracle Corporation's 3. 66x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, NICE Ltd. (NICE) trades at 8. 7x forward P/E versus 26. 0x for Oracle Corporation — 17. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NOW: 61. 9% to $151. 52.
08Which pays a better dividend — PEGA or NICE or CRM or NOW or ORCL?
In this comparison, CRM (0.
9% yield), ORCL (0. 9% yield), PEGA (0. 2% yield) pay a dividend. NICE, NOW do not pay a meaningful dividend and should not be held primarily for income.
09Is PEGA or NICE or CRM or NOW or ORCL better for a retirement portfolio?
For long-horizon retirement investors, Salesforce, Inc.
(CRM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 82), 0. 9% yield, +154. 6% 10Y return). Both have compounded well over 10 years (CRM: +154. 6%, NOW: +38. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PEGA and NICE and CRM and NOW and ORCL?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PEGA is a small-cap high-growth stock; NICE is a small-cap deep-value stock; CRM is a mid-cap quality compounder stock; NOW is a mid-cap high-growth stock; ORCL is a large-cap quality compounder stock. CRM, ORCL pay a dividend while PEGA, NICE, NOW do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.